Answers are grounded in this paper and cite their sources.
Sir, We have read with great interest the recent paper by Palmer [1] dealing with hyponatraemia (with natriuresis) developing in neurosurgical patients. Although hyponatraemia in such patients is generally attributed to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH), in most patients it is actually caused by a renal salt loss which leads to hyponatraemia and volume depletion (the so‐called cerebral salt wasting syndrome [CSWS]) [2]. This creates a diagnostic dilemma where two distinct groups of patients have virtually identical clinical signs, laboratory abnormalities and overlapping associated diseases (intracranial pathology). On the other hand, distinguishing between these disorders is of paramount importance with regard to therapy, since the appropriate treatment of CSWS (fluid replacement) is quite opposite to the treatment of SIADH (fluid restriction). As stressed by Dr Palmer, volume status may be the only contrasting variable between the euvolaemic patient with SIADH and the hypovolaemic renal salt waster with CSWS. Yet, in contrast with the optimistic statement by Dr Palmer, clinical assessment of the extracellular volume by non‐invasive parameters is quite inaccurate in these patients [3].
No takes yet. Share an insight, caveat, or question.
Docci et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: